Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 3/20 | 0.45 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.45 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.45 |
| ▸ | PRKACA | P17612 | 1/20 | 0.45 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.45 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.45 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.45 |
| ▸ | PRKD2 | Q9BZL6 | 1/20 | 0.45 |
| ▸ | TAOK1 | Q7L7X3 | 2/20 | 0.44 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.44 |
| ▸ | EEF2K | O00418 | 1/20 | 0.44 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.44 |
| ▸ | CLK2 | P49760 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.44 |
| ▸ | PRKX | P51817 | 1/20 | 0.44 |
| ▸ | NEK4 | P51957 | 1/20 | 0.44 |
| ▸ | PRKG2 | Q13237 | 1/20 | 0.44 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.44 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.44 |
| ▸ | PBK | Q96KB5 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31467143 | 1.00 | ROCK2 (0.45) | ROCK2ROCK1CHEK2PRKACARPS6KA3 | |
| SCHEMBL9989317 | 0.85 | ROCK2 (0.41) | ROCK2ROCK1CHEK2PRKACARPS6KA3 | |
| SCHEMBL13539429 | 0.82 | SLC22A12 (0.52) | ROCK2ROCK1CHEK2PRKACARPS6KA3 | |
| SCHEMBL31414297 | 0.82 | ROCK2 (0.49) | ROCK2ROCK1CHEK2PRKACARPS6KA3 | |
| SCHEMBL20139305 | 0.82 | ROCK2 (0.49) | ROCK2ROCK1CHEK2PRKACARPS6KA3 | |
| SCHEMBL13165280 | 0.81 | ROCK2 (0.46) | ROCK2ROCK1CHEK2PRKACARPS6KA3 | |
| SCHEMBL625971 | 0.81 | TAOK1 (0.65) | ROCK2ROCK1CHEK2PRKACARPS6KA3 | |
| SCHEMBL10588 | 0.81 | ROCK2 (0.46) | ROCK2ROCK1CHEK2PRKACARPS6KA3 | |
| SCHEMBL2481963 | 0.81 | EGFR (0.48) | ROCK2ROCK1CHEK2PRKACARPS6KA3 | |
| SCHEMBL10325766 | 0.80 | ROCK2 (0.46) | ROCK2ROCK1CHEK2PRKACARPS6KA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023069884-A1 | KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE | IMAGO BIOSCIENCES, INC. (US) | 2023-04-27 | — | — | WO | disclosed |
| US-9630961-B2 | Arginine methyltransferase inhibitors and uses thereof | Epizyme, Inc. (US) | 2017-04-25 | — | — | US | disclosed |
| US-9630961-B2 | Arginine methyltransferase inhibitors and uses thereof | Epizyme, Inc. (US) | 2017-04-25 | — | — | US | disclosed |
| US-9630961-B2 | Arginine methyltransferase inhibitors and uses thereof | Epizyme, Inc. (US) | 2017-04-25 | — | — | US | disclosed |
| US-20160185772-A1 | ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF | MAGSEIS FF LLC | 2016-06-30 | — | — | US | disclosed |
| US-20160185772-A1 | ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF | MAGSEIS FF LLC | 2016-06-30 | — | — | US | disclosed |
| US-20160185772-A1 | ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF | MAGSEIS FF LLC | 2016-06-30 | — | — | US | disclosed |
| EP-2970136-A1 | ARGININE METHYL TRANSFERASE INHIBTORS AND USES THEREOF | Epizyme, Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| US-9133189-B2 | Arginine methyltransferase inhibitors and uses thereof | Epizyme, Inc. (US) | 2015-09-15 | — | — | US | disclosed |
| US-9133189-B2 | Arginine methyltransferase inhibitors and uses thereof | Epizyme, Inc. (US) | 2015-09-15 | — | — | US | disclosed |
| WO-2014153214-A1 | ARGININE METHYL TRANSFERASE INHIBTORS AND USES THEREOF | Epizyme, Inc. (US) | 2014-09-25 | — | — | WO | disclosed |
| WO-2014153214-A1 | ARGININE METHYL TRANSFERASE INHIBTORS AND USES THEREOF | Epizyme, Inc. (US) | 2014-09-25 | — | — | WO | disclosed |
| US-20140288105-A1 | ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2014-09-25 | — | — | US | disclosed |
| US-20140288105-A1 | ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2014-09-25 | — | — | US | disclosed |
| US-20140288105-A1 | ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2014-09-25 | — | — | US | disclosed |
| US-20110312903-A1 | FLUORINATION OF ORGANIC COMPOUNDS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2011-12-22 | — | — | US | disclosed |
| EP-2376408-A2 | FLUORINATION OF ORGANIC COMPOUNDS | President and Fellows of Harvard College (US) | 2011-10-19 | — | — | EP | disclosed |
| WO-2010059943-A2 | FLUORINATION OF ORGANIC COMPOUNDS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-05-27 | — | — | WO | disclosed |
| WO-2010059943-A2 | FLUORINATION OF ORGANIC COMPOUNDS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-05-27 | — | — | WO | disclosed |
| US-20090258907-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ROCK KINASES | ABBOTT LABORATORIES (US) | 2009-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110312903-A1 | FLUORINATION OF ORGANIC COMPOUNDS | SLCO1B3, SLCO2B1, FLI1 | ROCK2 1379/4885ROCK1 1835/4885CHEK2 1627/4885 |
| US-20090258907-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ROCK KINASES | ROCK1, ROCK2, RHOA | ROCK2 2/4885ROCK1 1/4885CHEK2 280/4885 |
| US-20160185772-A1 | ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF | PRMT1, PRMT3, PRMT5 | ROCK2 438/4885ROCK1 297/4885CHEK2 1814/4885 |
| US-20140288105-A1 | ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF | PRMT1, PRMT3, PRMT5 | ROCK2 438/4885ROCK1 297/4885CHEK2 1814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.